
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (27): 3358-3364.DOI: 10.12114/j.issn.1007-9572.2022.0263
Special Issue: 老年问题最新文章合辑; 呼吸疾病文章合辑
• Article • Previous Articles Next Articles
Received:2022-03-12
Revised:2022-04-20
Published:2022-09-20
Online:2022-06-23
Contact:
Muyun ZHU
About author:
通讯作者:
朱慕云
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0263
| 组别 | 例数 | 性别〔n(%)〕 | 年龄( | BMI( | 吸烟量( | PMcsa( | PMI( | |
|---|---|---|---|---|---|---|---|---|
| 男 | 女 | |||||||
| GOLDⅠ级组 | 47 | 37(78.7) | 10(21.3) | 69.0±5.9 | 24.0±3.1 | 24.37±12.68 | 23.64±8.30 | 8.48±2.71 |
| GOLDⅡ级组 | 88 | 71(80.7) | 17(19.3) | 71.1±7.3 | 23.5±3.4 | 25.35±13.69 | 19.94±5.74b | 7.21±1.97b |
| GOLDⅢ级组 | 84 | 70(83.3) | 14(16.7) | 72.3±7.9 | 22.8±3.3b | 25.36±13.83 | 16.78±5.00bc | 6.04±1.70bc |
| GOLDⅣ级组 | 51 | 42(82.3) | 9(17.7) | 71.0±6.6 | 21.4±3.0bcd | 26.40±15.69 | 14.19±4.60bcd | 5.22±1.61bcd |
| F(χ2)值 | 0.491a | 2.292 | 6.587 | 0.056 | 25.902 | 27.776 | ||
| P值 | 0.921 | 0.078 | 0.001 | 0.982 | <0.001 | <0.001 | ||
| 组别 | PMD( | FEV1%pred( | FEV1( | FVC( | 肺体积( | 右肺LAA%( | 左肺LAA%( | 总肺LAA%( |
| GOLDⅠ级组 | 36.49±12.42 | 87.23±7.14 | 2.00±0.46 | 2.90±0.62 | 5.18±1.07 | 13.21±6.65 | 13.81±6.95 | 13.54±6.77 |
| GOLDⅡ级组 | 35.01±10.40 | 61.14±7.89b | 1.55±0.38b | 2.49±0.66b | 5.31±1.36 | 15.37±8.93b | 15.32±8.37b | 15.35±8.59b |
| GOLDⅢ级组 | 32.97±11.46b | 41.17±6.05bc | 1.19±0.36bc | 2.22±0.65bc | 5.48±1.40 | 18.66±7.77bc | 18.86±8.66bc | 18.89±7.90bc |
| GOLDⅣ级组 | 30.99±8.84bcd | 25.86±4.45bcd | 0.91±0.43bcd | 1.82±0.69bcd | 5.36±0.99 | 25.23±8.42bcd | 24.24±7.30bcd | 24.88±7.85bcd |
| F(χ2)值 | 2.673 | 851.052 | 73.969 | 24.910 | 0.621 | 22.600 | 18.319 | 21.649 |
| P值 | 0.048 | <0.001 | <0.001 | <0.001 | 0.602 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of clinical data of patients with different grades of COPD
| 组别 | 例数 | 性别〔n(%)〕 | 年龄( | BMI( | 吸烟量( | PMcsa( | PMI( | |
|---|---|---|---|---|---|---|---|---|
| 男 | 女 | |||||||
| GOLDⅠ级组 | 47 | 37(78.7) | 10(21.3) | 69.0±5.9 | 24.0±3.1 | 24.37±12.68 | 23.64±8.30 | 8.48±2.71 |
| GOLDⅡ级组 | 88 | 71(80.7) | 17(19.3) | 71.1±7.3 | 23.5±3.4 | 25.35±13.69 | 19.94±5.74b | 7.21±1.97b |
| GOLDⅢ级组 | 84 | 70(83.3) | 14(16.7) | 72.3±7.9 | 22.8±3.3b | 25.36±13.83 | 16.78±5.00bc | 6.04±1.70bc |
| GOLDⅣ级组 | 51 | 42(82.3) | 9(17.7) | 71.0±6.6 | 21.4±3.0bcd | 26.40±15.69 | 14.19±4.60bcd | 5.22±1.61bcd |
| F(χ2)值 | 0.491a | 2.292 | 6.587 | 0.056 | 25.902 | 27.776 | ||
| P值 | 0.921 | 0.078 | 0.001 | 0.982 | <0.001 | <0.001 | ||
| 组别 | PMD( | FEV1%pred( | FEV1( | FVC( | 肺体积( | 右肺LAA%( | 左肺LAA%( | 总肺LAA%( |
| GOLDⅠ级组 | 36.49±12.42 | 87.23±7.14 | 2.00±0.46 | 2.90±0.62 | 5.18±1.07 | 13.21±6.65 | 13.81±6.95 | 13.54±6.77 |
| GOLDⅡ级组 | 35.01±10.40 | 61.14±7.89b | 1.55±0.38b | 2.49±0.66b | 5.31±1.36 | 15.37±8.93b | 15.32±8.37b | 15.35±8.59b |
| GOLDⅢ级组 | 32.97±11.46b | 41.17±6.05bc | 1.19±0.36bc | 2.22±0.65bc | 5.48±1.40 | 18.66±7.77bc | 18.86±8.66bc | 18.89±7.90bc |
| GOLDⅣ级组 | 30.99±8.84bcd | 25.86±4.45bcd | 0.91±0.43bcd | 1.82±0.69bcd | 5.36±0.99 | 25.23±8.42bcd | 24.24±7.30bcd | 24.88±7.85bcd |
| F(χ2)值 | 2.673 | 851.052 | 73.969 | 24.910 | 0.621 | 22.600 | 18.319 | 21.649 |
| P值 | 0.048 | <0.001 | <0.001 | <0.001 | 0.602 | <0.001 | <0.001 | <0.001 |
| 项目 | FEV1%pred | FEV1 | FVC | |||
|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | |
| PMcsa | 0.589 | <0.01 | 0.326 | <0.01 | 0.419 | <0.01 |
| PMI | 0.623 | <0.01 | 0.411 | <0.01 | 0.410 | <0.01 |
| PMD | 0.232 | <0.01 | 0.227 | <0.01 | 0.281 | <0.01 |
| 右肺LAA% | -0.525 | <0.01 | -0.270 | <0.01 | -0.091 | 0.13 |
| 左肺LAA% | -0.501 | <0.01 | -0.251 | <0.01 | -0.044 | 0.47 |
| 总肺LAA% | -0.538 | <0.01 | -0.273 | <0.01 | -0.064 | 0.29 |
| 肺体积 | -0.061 | 0.31 | 0.014 | 0.81 | 0.149 | 0.01 |
Table 2 Correlation analysis of pectoralis major muscle parameters,low attenuation area ratio and lung function
| 项目 | FEV1%pred | FEV1 | FVC | |||
|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | |
| PMcsa | 0.589 | <0.01 | 0.326 | <0.01 | 0.419 | <0.01 |
| PMI | 0.623 | <0.01 | 0.411 | <0.01 | 0.410 | <0.01 |
| PMD | 0.232 | <0.01 | 0.227 | <0.01 | 0.281 | <0.01 |
| 右肺LAA% | -0.525 | <0.01 | -0.270 | <0.01 | -0.091 | 0.13 |
| 左肺LAA% | -0.501 | <0.01 | -0.251 | <0.01 | -0.044 | 0.47 |
| 总肺LAA% | -0.538 | <0.01 | -0.273 | <0.01 | -0.064 | 0.29 |
| 肺体积 | -0.061 | 0.31 | 0.014 | 0.81 | 0.149 | 0.01 |
| 变量 | 系数(95%CI) | SE | t值 | P值 |
|---|---|---|---|---|
| 常量 | 35.519(25.852,45.186) | 4.910 | 7.234 | <0.001 |
| 性别 | 10.215(4.064,16.365) | 3.124 | 3.270 | 0.001 |
| 总肺LAA% | -0.698(-0.950,-0.446) | 0.128 | -5.456 | <0.001 |
| PMcsa | 1.506(1.154,1.857) | 0.178 | 8.436 | <0.001 |
Table 3 Multiple linear regression analysis of PMcsa,LAA% and lung function indicators in COPD patiens
| 变量 | 系数(95%CI) | SE | t值 | P值 |
|---|---|---|---|---|
| 常量 | 35.519(25.852,45.186) | 4.910 | 7.234 | <0.001 |
| 性别 | 10.215(4.064,16.365) | 3.124 | 3.270 | 0.001 |
| 总肺LAA% | -0.698(-0.950,-0.446) | 0.128 | -5.456 | <0.001 |
| PMcsa | 1.506(1.154,1.857) | 0.178 | 8.436 | <0.001 |
| 项目 | 男 | 女 | ||||||
|---|---|---|---|---|---|---|---|---|
| AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
| 右肺LAA% | 0.832(0.769,0.885) | 15.25 | 0.841 | 0.727 | 0.844(0.735,0.953) | 14.62 | 0.792 | 0.801 |
| 左肺LAA% | 0.827(0.777,0.887) | 15.85 | 0.833 | 0.715 | 0.801(0.669,0.920) | 13.85 | 0.625 | 0.754 |
| 总肺LAA% | 0.834(0.778,0.891) | 16.71 | 0.807 | 0.784 | 0.845(0.737,0.954) | 13.61 | 0.792 | 0.753 |
| PMcsa | 0.809(0.742,0.858) | 19.05 | 0.667 | 0.881 | 0.839(0.726,0.953) | 13.96 | 0.769 | 0.871 |
Table 4 Efficacy of PMcsa and low attenuation area ratio in predicting FEV1% pred<50% in patients of different genders
| 项目 | 男 | 女 | ||||||
|---|---|---|---|---|---|---|---|---|
| AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
| 右肺LAA% | 0.832(0.769,0.885) | 15.25 | 0.841 | 0.727 | 0.844(0.735,0.953) | 14.62 | 0.792 | 0.801 |
| 左肺LAA% | 0.827(0.777,0.887) | 15.85 | 0.833 | 0.715 | 0.801(0.669,0.920) | 13.85 | 0.625 | 0.754 |
| 总肺LAA% | 0.834(0.778,0.891) | 16.71 | 0.807 | 0.784 | 0.845(0.737,0.954) | 13.61 | 0.792 | 0.753 |
| PMcsa | 0.809(0.742,0.858) | 19.05 | 0.667 | 0.881 | 0.839(0.726,0.953) | 13.96 | 0.769 | 0.871 |
| 项目 | 男 | 女 | ||||||
|---|---|---|---|---|---|---|---|---|
| AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
| 右肺LAA% | 0.830(0.753,0.898) | 9.85 | 0.861 | 0.647 | 0.805(0.657,0.933) | 7.25 | 0.897 | 0.641 |
| 左肺LAA% | 0.815(0.738,0.885) | 9.80 | 0.873 | 0.638 | 0.817(0.697,0.938) | 6.98 | 0.825 | 0.653 |
| 总肺LAA% | 0.831(0.760,0.899) | 9.28 | 0.887 | 0.643 | 0.807(0.675,0.939) | 7.23 | 0.882 | 0.624 |
| PMcsa | 0.844(0.784,0.907) | 24.82 | 0.667 | 0.881 | 0.846(0.714,0.977) | 15.03 | 0.755 | 0.811 |
Table 5 Efficacy of PMcsa and low attenuation area ratio in predicting FEV1% pred<80% in patients of different genders
| 项目 | 男 | 女 | ||||||
|---|---|---|---|---|---|---|---|---|
| AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
| 右肺LAA% | 0.830(0.753,0.898) | 9.85 | 0.861 | 0.647 | 0.805(0.657,0.933) | 7.25 | 0.897 | 0.641 |
| 左肺LAA% | 0.815(0.738,0.885) | 9.80 | 0.873 | 0.638 | 0.817(0.697,0.938) | 6.98 | 0.825 | 0.653 |
| 总肺LAA% | 0.831(0.760,0.899) | 9.28 | 0.887 | 0.643 | 0.807(0.675,0.939) | 7.23 | 0.882 | 0.624 |
| PMcsa | 0.844(0.784,0.907) | 24.82 | 0.667 | 0.881 | 0.846(0.714,0.977) | 15.03 | 0.755 | 0.811 |
| [1] |
陈亚红. 2019年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版),2019,11(1):1-14. DOI:10.12037/YXQY.2019.01-01.
|
| [2] |
|
| [3] |
|
| [4] |
刘金良,庞军,李晓冬,等. 慢性阻塞性肺疾病患者胸部定量CT参数与肺功能检测指标相关性分析[J]. 临床肺科杂志,2020,25(12):1831-1835. DOI:10.3969/j.issn.1009-6663.2020.12.012.
|
| [5] |
|
| [6] |
沈宁,贺蓓. 肺功能检查在慢性阻塞性肺疾病诊断及治疗中的临床意义[J]. 中华结核和呼吸杂志,2019,42(1):73-78. DOI:10.3760/cma.j.issn.1001-0939.2019.01.023.
|
| [7] |
文富强,申永春,陈磊. 肺功能检查在中国慢性阻塞性肺疾病患者中的实践:挑战与对策[J]. 中华结核和呼吸杂志,2017,40(12):891-893. DOI:10.3760/cma.j.issn.1001-0939.2017.12.004.
|
| [8] |
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 常规肺功能检查基层指南(2018年)[J]. 中华全科医师杂志,2019,18(6):511-518. DOI:10.3760/cma.j.issn.1671-7368.2019.06.003.
|
| [9] |
|
| [10] |
李艳,高俊刚,郭佑民,等. 支气管炎型和肺气肿型COPD患者CT定量指标及肺功能的纵向变化研究[J]. 临床放射学杂志,2020,39(6):1104-1107. DOI:10.13437/j.cnki.jcr.2020.06.017.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
任涛. 基于MSCT慢性阻塞性肺疾病定量参数对肺功能指标的预测价值[D]. 银川:宁夏医科大学,2021.
|
| [18] |
董中兴,沈慧君,龚李艳,等. 肺叶低密度区容积百分比对慢性阻塞性肺病患者肺功能受损程度的评估作用[J]. 内科急危重症杂志,2017,23(5):365-367,374. DOI:10.11768/nkjwzzzz20170504.
|
| [19] |
兰长青,王洁,黄梅萍,等. CT肺气肿指数及空间分布对慢性阻塞性肺疾病肺损伤的评估价值[J]. 中国临床医学影像杂志,2021,32(5):320-325. DOI:10.12117/jccmi.2021.05.004.
|
| [20] |
|
| [21] |
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||